XML 98 R83.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Components Deferred Taxes (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 32,887 $ 42,182
Deferred revenue 837 909
Research and development and orphan drug credits 96,133 109,041
Share-based compensation 6,353 1,814
ASC 842 lease liability 2,480 600
Capitalized research expense 10,168 0
Transaction related expense 2,354 0
Inventory related reserves 18,395 0
Interest expense limitation 0 0
Other, net 3,054 3,449
Deferred Tax Assets, Gross 172,661 157,995
Valuation allowance for deferred tax assets (707) (500)
Deferred tax assets, net of valuation allowance 171,954 157,495
Non-deductible book amortization (115,578)  
Depreciation (2,559) (1,185)
Convertible note 0 (17)
ASC 842 right of use asset (9,061) (426)
Other, net (330) (433)
Total deferred tax liabilities (127,528) (2,061)
Net deferred tax asset $ 44,426 $ 155,434